MESO

Mesoblast Limited develops medical treatments using specialized cells called mesenchymal lineage cells, which are cells that can develop into different types of tissue to repair damaged areas of the body. The company is testing its main treatment, Remestemcel-L, in late-stage clinical trials for diseases including heart failure, inflammatory bowel disease, and back pain caused by disc degeneration. It is also developing other cell-based treatments for conditions like rheumatoid arthritis and heart attacks, working with pharmaceutical partners in different countries to bring these treatments to…